ATE455778T1 - Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat - Google Patents

Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat

Info

Publication number
ATE455778T1
ATE455778T1 AT04820865T AT04820865T ATE455778T1 AT E455778 T1 ATE455778 T1 AT E455778T1 AT 04820865 T AT04820865 T AT 04820865T AT 04820865 T AT04820865 T AT 04820865T AT E455778 T1 ATE455778 T1 AT E455778T1
Authority
AT
Austria
Prior art keywords
clopidogrelbisulphate
producing form
preparation
improved processes
clopidogrel bisulfate
Prior art date
Application number
AT04820865T
Other languages
English (en)
Inventor
Braj Lohray
Vidya Lohray
Bipin Pandey
Mayank Ghanshyambhai Dave
Parind Dholakia
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Application granted granted Critical
Publication of ATE455778T1 publication Critical patent/ATE455778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT04820865T 2003-11-03 2004-11-02 Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat ATE455778T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1154MU2003 2003-11-03
IN1217MU2003 2003-11-25
PCT/IN2004/000341 WO2005063708A2 (en) 2003-11-03 2004-11-02 Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate

Publications (1)

Publication Number Publication Date
ATE455778T1 true ATE455778T1 (de) 2010-02-15

Family

ID=34740781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04820865T ATE455778T1 (de) 2003-11-03 2004-11-02 Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat

Country Status (12)

Country Link
US (2) US8907090B2 (de)
EP (2) EP1680430B1 (de)
KR (2) KR101050105B1 (de)
AT (1) ATE455778T1 (de)
CA (2) CA2676121A1 (de)
DE (1) DE602004025267D1 (de)
DK (1) DK1680430T3 (de)
ES (1) ES2339944T3 (de)
NO (1) NO20062062L (de)
PL (1) PL1680430T3 (de)
PT (1) PT1680430E (de)
WO (1) WO2005063708A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004081016A1 (en) * 2003-03-12 2004-09-23 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
EP2113506A3 (de) * 2003-04-25 2010-02-24 Cadila Healthcare Limited Salze aus Clopidogrel und Herstellungsverfahren dafür
PT1680430E (pt) * 2003-11-03 2010-04-26 Cadila Healthcare Ltd Processos para a preparação da forma i de bissulfato de (s)-(+)-clopidogrel
WO2006074066A1 (en) * 2004-12-30 2006-07-13 Nektar Therapeutics Non-crystalline formulation comprising clopidogrel
KR20070066518A (ko) * 2005-12-22 2007-06-27 에스케이케미칼주식회사 고체상 반응을 이용한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
US20090093635A1 (en) * 2006-03-09 2009-04-09 Sandor Garadnay PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE
KR101378596B1 (ko) * 2006-12-27 2014-03-26 경동제약 주식회사 결정성 클로피도그렐 · 황산염 형태 ｉ의 제조방법
EP2107061A1 (de) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Herstellungsverfahren für optisch angereichertes Clopidogrel
CA2725997A1 (en) * 2008-06-24 2009-12-30 Zach System S.P.A. Process for the preparation of clopidogrel hydrogen sulfate crystalline form i
KR101616928B1 (ko) * 2010-01-07 2016-05-02 동화약품주식회사 클로피도그렐 황산수소염 결정형（ｉ）의 제조방법
CN102558194A (zh) * 2010-12-11 2012-07-11 山东方明药业股份有限公司 一种硫酸氢氯吡格雷i型的制备方法
KR101567438B1 (ko) 2013-11-15 2015-11-12 대구가톨릭대학교산학협력단 클로피도그렐 황산염 결정형 ⅰ형의 제조방법
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
CN107163060B (zh) * 2017-05-24 2021-03-02 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型ii制备方法
CN113121559B (zh) * 2019-12-31 2023-08-29 惠州信立泰药业有限公司 一种高堆密度的ii型硫酸氢氯吡格雷球形结晶及制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664276B1 (fr) 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.
FR2664596B1 (fr) 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
US5139170A (en) 1990-09-06 1992-08-18 Ad-Tech Plastic Systems Corp. Dispensing apparatus for multiple fluids
FR2760456B1 (fr) 1997-03-05 2000-05-12 Sanofi Sa Procede de preparation de derives de 2-thienyl-ethylamine
HU225504B1 (en) 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HU222283B1 (hu) 1997-05-13 2003-05-28 Sanofi-Synthelabo Eljárás tieno[3,2-c]piridin-származékok előállítására
HU225503B1 (en) 1997-05-13 2007-01-29 Sanofi Aventis Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them
FR2769313B1 (fr) 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
KR20060040758A (ko) 2001-01-24 2006-05-10 카딜라 헬스케어 리미티드 티에노[3,2-ｃ]피리딘 유도체의 제조방법
IN191030B (de) 2001-01-24 2003-09-13 Cadila Healthcare Ltd
CA2470479A1 (en) 2001-12-18 2003-06-26 Teva Pharmaceutical Industries Ltd. Polymorphs of clopidogrel hydrogensulfate
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
DE10305984A1 (de) 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
WO2004081016A1 (en) 2003-03-12 2004-09-23 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
EP2113506A3 (de) 2003-04-25 2010-02-24 Cadila Healthcare Limited Salze aus Clopidogrel und Herstellungsverfahren dafür
BR0318449A (pt) * 2003-08-04 2006-08-01 Wockhardt Ltd processo para fabricação de (+)-(s)-clopidogrel bissulfato forma-i
PT1680430E (pt) 2003-11-03 2010-04-26 Cadila Healthcare Ltd Processos para a preparação da forma i de bissulfato de (s)-(+)-clopidogrel
CA2562532C (en) 2004-04-09 2010-02-16 Hanmi Pharm. Co., Ltd. Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
EP1704152A2 (de) 2004-09-21 2006-09-27 Teva Pharmaceutical Industries Ltd Kristallines clopidogrelhydrobromid und verfahren zu dessen herstellung
US7446200B2 (en) 2004-10-04 2008-11-04 Usv, Ltd. Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
US20080188663A1 (en) 2007-01-29 2008-08-07 Ashok Kumar Process for the preparation of crystalline clopidogrel hydrogen sulphate Form I

Also Published As

Publication number Publication date
PT1680430E (pt) 2010-04-26
EP2103617A1 (de) 2009-09-23
KR20110010809A (ko) 2011-02-07
US8907090B2 (en) 2014-12-09
DK1680430T3 (da) 2010-05-25
CA2676121A1 (en) 2005-07-14
KR101050105B1 (ko) 2011-07-19
CA2544443A1 (en) 2005-07-14
NO20062062L (no) 2006-07-24
PL1680430T3 (pl) 2010-06-30
CA2544443C (en) 2010-08-17
US20070082924A1 (en) 2007-04-12
WO2005063708A2 (en) 2005-07-14
EP1680430A2 (de) 2006-07-19
US20100204268A1 (en) 2010-08-12
ES2339944T3 (es) 2010-05-27
EP1680430B1 (de) 2010-01-20
KR20070006679A (ko) 2007-01-11
WO2005063708A3 (en) 2005-10-06
KR101110738B1 (ko) 2012-02-17
DE602004025267D1 (de) 2010-03-11

Similar Documents

Publication Publication Date Title
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
DE60325188D1 (de) Verfahren zur herstellung von sterilen, stabilisierten nanodispersionen
DE60224643D1 (de) Verfahren zur herstellung von reifen
ATE453648T1 (de) Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
DE60304828D1 (de) Verfahren zur herstellung von nanopartikeln von block-copolymeren
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
ATE455778T1 (de) Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
DE60324813D1 (de) Verfahren zur Herstellung von Wellenleitern
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
DE602004020895D1 (de) Verfahren zur herstellung von kohlenstoffnanospulen
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
DE60204334D1 (de) Verfahren zur herstellung von repaglinide
DE50302740D1 (de) Verfahren zur herstellung von verküpbaren organischen pigmenten
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
ATE453619T1 (de) Verfahren zur herstellung von hydroperoxiden
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE60210911D1 (de) Verfahren zur Herstellung von dehnungserfassenden Vorrichtungen
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
ATE273315T1 (de) Verfahren zur herstellung von n- phosphonomethyliminodiessigsäure
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE323677T1 (de) Verfahren zur herstellung von 4-amino-2,5- bisheterocyclylchinazolinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties